A study has shown that unlike opioids like morphine, the experimental painkiller does not cause tolerance, meaning you don't ...

Costa Mesa is set to receive $4.6 million over 15 years as part of the nationwide legal settlements against drug makers and ...

Opioid agonist/antagonist has a big impact in phase IIb trial ...

LOS ANGELES, CA - January 15, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has released ...

Infants exposed to opioids and psychotropic drugs during pregnancy have a 30% to 60% higher risk of experiencing neonatal withdrawal, a study has found. That risk doubles when multiple psychotropic ...

As more Americans receive treatment for opioid-use disorder, that progress is increasingly showing up in the operating room, ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

A clinical trial of an experimental drug for treatment-resistant major depression finds that modulation of the endogenous opioid system may improve the effectiveness of drugs that target the action of ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...